The Tyranny of Distance
January 2011
in “
Clinical Cosmetic and Investigational Dermatology
”
Studysummary This review discusses spironolactone as an effective and potentially safer treatment for androgenic alopecia, particularly when used with minoxidil, but calls for more high-quality clinical trials.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
Spironolactone was found to be an effective and safe treatment for androgenic alopecia, particularly when used in combination with conventional treatments like minoxidil. Topical application of spironolactone was considered safer than oral administration and was suitable for both male and female patients. It was anticipated to become a common treatment option for individuals who did not respond well to minoxidil. The document also suggested that more high-quality clinical randomized controlled studies were needed to further validate these findings.
